IN BRIEF: Verona Pharma Says Third Quarter Loss Widens Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq Read More
IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec Read More
Verona Pharma Says Study Shows Ensifentrine Improves Lung Function Read More
Verona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial Read More
LONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine Read More
UK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows Read More
Verona To Trial Ensifentrine For Covid-19; First Half Loss Widens Read More
LONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale Read More
UK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise Read More
Verona Pharma Shares Surge As It Raises USD200 Million For Drug Trial Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
UK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus Read More
Verona Pharma Changes Top Management With New CEO, Finance Head Read More
UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance Read More
Verona Pharma Says Ensifentrine Study Shows Positive Results Read More
UK WINNERS & LOSERS SUMMARY: AB Foods Rises As Primark Adds US Stores Read More
Verona Pharma Third Quarter Loss Widens On Research & Development Read More
(Alliance News) - Verona Pharma PLC on Tuesday said its loss widened in the second quarter and the first half of 2019 as it progressed on clinical trials of Ensifentrine, used for the treatment of Read More
